Amsterdam UMC

Anxiety and depression medication use rose significantly among women in the 5 years after out-of-hospital cardiac arrest, according to a real-world study published in Circulation: Cardiovascular Quality and Outcomes.

Transgender girls see most of their body composition changes occur during puberty suppression, whereas transgender boys experience greater body composition changes during gender-confirming testosterone therapy, according to study data.

Data from a survey conducted in the Netherlands show most cardiologists do not routinely screen for cognitive impairment in older patients with HF, but they were open to the idea of a dedicated “heart-brain clinic” to give such full care.

Transgender people who use gender-confirming hormone therapy long term have increases in bone mineral density back to levels observed before pubertal suppression, according to findings published in JAMA Pediatrics.

Resumption of elite-level sports after recovery from COVID-19 is “safe and feasible,” according to a prospective study of Dutch athletes.

Withholding prophylactic platelet transfusion before placement of a central venous catheter in patients with severe thrombocytopenia resulted in more catheter-related bleeding events, results of a randomized noninferiority trial showed.

Women with growth hormone deficiency treated with GH therapy have lower insulin-like growth factor I levels at both baseline and follow-up and experience more adverse events than men, according to study data.

Compared with boys, girls with type 1 diabetes have worse HbA1c, higher BMI and more diabetic ketoacidosis and require higher insulin doses, according to a systematic review published in Diabetologia.

The humanities, from music and painting to literature and poetry, offer limitless opportunities to grow as a professional and as an individual.

NEW ORLEANS — The use of low-molecular-weight heparin among pregnant women with a history of recurrent miscarriage and inherited thrombophilia had no effect on the live birth rate, results from the phase 3 ALIFE2 trial showed.